TITLE

Jejunal Metastasis Colliding With a Borderline Tumor in the Ovary

AUTHOR(S)
Piana, Simonetta; Giunta, Alessandro; Valli, Riccardo
PUB. DATE
October 2015
SOURCE
International Journal of Surgical Pathology;Oct2015, Vol. 23 Issue 7, p567
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Metastatic adenocarcinomas to the ovary can show morphologically innocuous areas simulating primary benign lesions or borderline tumors. Ruling out a metastasis can be a difficult issue for pathologists, especially when facing with cystic tumors. Because of the important clinical implications of differentiating metastatic adenocarcinomas from primary ovarian tumors, the integration of clinical, pathological, and immunohistochemical features is warranted, primarily in case of mucinous adenocarcinomas. Vice versa, the synchronous presence of a metastasis and a primary in the same ovary is virtually excluded as a very unlikely eventuality. Here, we describe a case of metastatic adenocarcinoma from the jejunum colliding with a seromucinous borderline tumor in the same ovary, an unreported eventuality so far.
ACCESSION #
109208405

 

Related Articles

  • Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide. Serpe, Loredana; Gallicchio, Margherita; Canaparo, Roberto; Dosio, Franco // Pharmacogenomics & Personalized Medicine;2014, Vol. 7, p31 

    Among the gynecological malignancies, ovarian cancer is the leading cause of mortality in developed countries. Treatment of ovarian cancer is based on surgery integrated with chemotherapy. Platinum-based drugs (cisplatin and carboplatin) comprise the core of first-line chemotherapy for patients...

  • Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Dreyling, M.; Ghielmini, M.; Marcus, R.; Salles, G.; Vitolo, U.; Ladetto, M. // Annals of Oncology;Sep2014 Supplement, Vol. 25 Issue suppl_3, piii76 

    No abstract available.

  • Targeted therapies and clinical trials in ovarian cancer†. Dancey, J. // Annals of Oncology;Dec2013 Supplement 10, Vol. 24, px59 

    Recent advances in molecular profiling have shown that cancers arising from the ovary are phenotypically and genetically heterogeneous. Within histologies, many mutations in druggable targets are uncommon in frequency but mutations leading to activation of specific signal transduction pathways...

  • Know warning signs for ovarian cancer. ELBENDARY, AL // South County Journal;3/20/2013, Vol. 48 Issue 12, pB2 

    In this article, the author suggests women to get diagnosed for ovarian cancer at an early stage for effective treatment.

  • Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study. Köbel, M; Madore, J; Ramus, S J; Clarke, B A; Pharoah, P D P; Deen, S; Bowtell, D D; Odunsi, K; Menon, U; Morrison, C; Lele, S; Bshara, W; Sucheston, L; Beckmann, M W; Hein, A; Thiel, F C; Hartmann, A; Wachter, D L; Anglesio, M S; Høgdall, E // British Journal of Cancer;12/9/2014, Vol. 111 Issue 12, p2297 

    Background:Folate receptor 1 (FOLR1) is expressed in the majority of ovarian carcinomas (OvCa), making it an attractive target for therapy. However, clinical trials testing anti-FOLR1 therapies in OvCa show mixed results and require better understanding of the prognostic relevance of FOLR1...

  • Laparoscopic ovarian transposition in patients with pelvic cancer. Žilinskas, Kastytis; Sabonytė-Balšaitienė, Živilė; Samalavičius, Narimantas Evaldas // Acta Medica Lituanica;2013, Vol. 20 Issue 4, p207 

    Background. The aim of this study was to evaluate the feasibility of laparoscopic ovarian transposition prior to radiation therapy on the preservation of hormonal function in the treatment of pelvic cancer. Materials and methods. A chart review of premenopausal women diagnosed with pelvic...

  • In vivo fate mapping of cryopreserved murine ovarian grafts. Chi-Huang Chen; Shun-Jen Tan; Chii-Ruey Tzeng // Journal of Ovarian Research;2014, Vol. 7 Issue 1, p1 

    Background Cryopreservation of ovarian tissue has been suggested as an alternative to restore fertility for ovarian failure before chemotherapy. Methods Ovaries of donor FVB/N-Tg (PolII-Luc) Ltc transgenic mice (n = 5) were cryopreserved and transplanted to the back muscles of recipient...

  • microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells. Shuo Chen; Xi Chen; Yin-Ling Xiu; Kai-Xuan Sun; Zhi-Hong Zong; Yang Zhao // Journal of Ovarian Research;2014, Vol. 7 Issue 1, p1 

    Background MicroRNAs (miRNAs) are non-coding, single-stranded small RNAs that regulate gene expression negatively, which is involved in fundamental cellular processes. In this study, we investigated the role of mi-490-3P in the development of drug resistance in ovarian cancer cells. Methods The...

  • Biochemiczne markery w skriningu raka jajnika. Tkaczuk-Włach, Joanna; Sobstyl, Małgorzata; Jakiel, Grzegorz // Menopausal Review / Przeglad Menopauzalny;2013, Vol. 12 Issue 5, p442 

    Ovarian cancer has the highest mortality rate among gynecological cancer. Despite the development of new treatments five-year survival rates fall below 20%. This article is a review of the knowledge of the current markers and potential screening tests and their role in early detection of ovarian...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics